Clinical Trial Update: Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency [Phase 4]

View source ↗

Summary

Phase 4 trial update on autologous cultivated limbal stem cell transplantation for restoration of corneal epithelium in patients with limbal stem cell deficienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limbal Stem Cell Deficiency

Drugs mentioned

• Autologous Cultivated Limbal Stem Cells Transplantation

Snippet

Sponsor: Holostem s.r.l. | Conditions: Limbal Stem Cells Deficiency | Phase 4 | Status: COMPLETED